Company Listing
Kesios Therapeutics

Kesios is developing novel oncology therapeutics with a lead candidate about to start clinical studies for multiple myeloma. CEO Paolo Paoletti, MD, formerly President of Oncology at GSK, leads the experienced management team. Kesios is a spin-out from Imperial College London.

BACK
Location
London, UK
CEO
Paolo Paoletti
Abingworth Partner
Kurt von Emster
Website Address

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

Kesios is developing novel oncology therapeutics with a lead candidate about to start clinical studies for multiple myeloma. CEO Paolo Paoletti, MD, formerly President of Oncology at GSK, leads the experienced management team. Kesios is a spin-out from Imperial College London.

Location
London, UK
CEO
Paolo Paoletti
Abingworth Partner
Kurt von Emster
Website Address
BACK
 
Copyright Abingworth 2017